Both in Biotechnology
C4 Therapeutics vs Eikon Therapeutics
Over the past year CCCC returned +78.9% and EIKN returned −51.6%; their daily moves had a correlation of 0.43.
CCCC +78.9% EIKN −51.6%Growth of $1, one year, split-adjusted
| Metric | CCCC | EIKN |
|---|---|---|
| Price | $3.06 | $7.26 |
| Market cap | $376.5M | $393.2M |
| Today | −3.77% | −11.89% |
| 1 month | +1.0% | −12.4% |
| 6 months | +6.3% | −24.8% |
| Year to date | +60.2% | — |
| 1 year | +34.2% | — |
| Revenue growth (YoY) | +2.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −355.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 10.7× | — |
| Net cash | $253.7M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 84.4% |
| Short % of float | 41.0% | 20.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).